CCMH
VIVO

Cornerstone Capital Management Holdings’s Meridian Bioscience Inc VIVO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$270K Buy
19,300
+16,700
+642% +$244K ﹤0.01% 1082
2017
Q3 		$37K Buy
+2,600
New +$37.1K ﹤0.01% 1220

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Cornerstone Capital Management Holdings's VIVO Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Meridian Bioscience Inc (VIVO) stake by 642% in Q4 2017, buying an estimated $244K and bringing the position to 19,300 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Cornerstone Capital Management Holdings first reported a position in VIVO in Q3 2017 and has held it in 2 quarters since. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

  • Cornerstone Capital Management Holdings held 19,300 shares of Meridian Bioscience Inc worth $270K as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 16,700 Meridian Bioscience Inc shares in Q4 2017, an estimated $244K.
  • Meridian Bioscience Inc made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1082 holding.
  • Cornerstone Capital Management Holdings first reported a position in Meridian Bioscience Inc in Q3 2017 and has held it in 2 quarters since.
  • 178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.